Sp1 is involved in H2O2-induced PUMA gene expression and apoptosis in colorectal cancer cells by Wang, Xinying et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
Journal of Experimental & Clinical 
Cancer Research
Open Access Research
Sp1 is involved in H2O2-induced PUMA gene expression and 
apoptosis in colorectal cancer cells
Xinying Wang, Jing Wang, Shiyong Lin, Yan Geng, Jide Wang and Bo Jiang*
Address: Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, PR China
Email: Xinying Wang - sunwingwxy@163.com; Jing Wang - wangjing5822@163.com; Shiyong Lin - lwly2002@163.com; 
Yan Geng - gytools@163.com; Jide Wang - wangjide@gmail.com; Bo Jiang* - drjiang@163.com
* Corresponding author    
Abstract
Background:  Reactive oxygen species (ROS) are intricately involved in tumor progression
through effects on proliferation, apoptosis and metastasis. But how ROS works is not well
understood. In previous study, we found PUMA (p53-upregulated modulator of apoptosis) played
an important role in oxaliplatin-induced apoptosis. In the present study, we detect the role of
PUMA in H2O2-induced apoptosis in colorectal cancer cells and investigate the potential
mechanism.
Methods and results: We showed that H2O2 stimulated the activity of a 493 PUMA promoter
reporter gene construct. Suppressing the expression of PUMA abrogated H2O2-induced apoptosis.
Deletion of the Sp1-binding sites also decreased the transactivation of PUMA promoter by H2O2.
Furthermore, induction of PUMA promoter activity by H2O2 was abrogated by PFT-α (a p53
inhibitor) and Mithramycin A (a Sp1 inhibitor), as compared with PFT-α alone. To determine the
effects of Sp1 on PUMA in H2O2-induced apoptosis, procaspase 3, procaspase 9 and procaspase 8
expression was assessed. Mithramycin A and PFT-α also reduced H2O2-induced apoptosis
synergistically and abrogated the expression of procaspase 3 and procaspase 9.
Conclusion: Our findings suggest that PUMA plays a role in H2O2-induced apoptosis, and that Sp1
works together with p53 in the regulation of H2O2-induced PUMA expression and apoptosis in
colorectal cancer cells. This study provides important regulatory insights in the mechanisms of ROS
in colorectal cancer.
Introduction
Recently, a large body of evidence indicates that ROS plays
a central role in intracellular and intercellular signal trans-
duction pathway in a variety of cellular process. Reactive
oxygen species (ROS) increased in colorectal cancer due to
increased aerobic metabolism and exposure to various
anti-cancer modalities such as ionizing radiation and
chemotherapeutic drugs [1]. Many factors are involved in
this process. ROS are capable of activating certain tran-
scription factors directly and thereby modulating the reg-
ulation of gene transcription. Several transcriptional
factors such as AP1, Sp1 [2,3], Smad [4] and snail are
potentially associated with ROS-triggered cellular process.
Apoptosis and cancer are opposed phenomena but ROS
have been widely reported to play a key role in both[5,6],
suggesting that the regulation of gene expression by oxi-
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dants, antioxidants and the redox state remains as a prom-
ising therapeutic approach. Hyperphysiological levels of
ROS cause DNA damage, mutation and activation of sev-
eral proto-oncogenes in normal cells [7,8]. On the other
hand, the DNA damage and initiation of signal transduc-
tion pathways caused by ROS contribute to the cytotoxic-
ity to cancer cells [9]. The mechanism involved is still
controversial and its ability to induce apoptosis in color-
ectal cancer is not yet fully understood.
It is generally recognized that oxidative stress is associated
with p53-dependent cell cycle arrest, DNA repair and
apoptosis [10,11], but a clear understanding of the down-
stream regulation mechanisms is still elusive. It has been
proposed that Bcl-2 regulates antioxidant pathways at
sites of free radical generation [12]. Another gene, called
p53 upregulated modulator of apoptosis (PUMA), was
identified through global profiling as a p53-inducible
gene. Yeast two-hybrid screening identified PUMA as a
Bcl-2 interacting protein [13]. PUMA is a proapoptotic
member of the Bcl-2 family and plays an important role
in stress-induced apoptosis. Yu et al [13] suggested that
PUMA could be directly activated by p53 through p53-
responsive elements in its promoter region. The protein
encoded by PUMA was exclusively localized to mitochon-
dria where it interacted with Bcl-2 and Bcl-xl through its
BH3 domain [14]. We have previously shown that oxali-
platin-induced ERK inactivation was involved in the regu-
lation of oxaliplatin-induced PUMA expression and
apoptosis [15]. We hypothesized that ROS had a direct
effect on PUMA.
In the present study, we found that PUMA plays a role in
H2O2-induced apoptosis in colorectal cancer cells. The
effects of H2O2 on the expression of PUMA and the mech-
anism by which this is regulated were examined. Our
results suggest that Sp1 plays a role in H2O2-induced
PUMA expression and apoptosis in colorectal cancer cells.
Comprehensive understanding of the ROS-triggered sig-
nal transduction, transcriptional activation and regulation
of gene expression will help to identify the critical role of
ROS in tumor progression and in defining a strategy for
chemo-therapeutic intervention.
Materials and methods
Materials
All reagents for cell culture were purchased from Invitro-
gen/Life Technologies (Carlsbad, CA, USA). Mithramycin
A (Mithr.A), pifithrin-alpha (PFT-α), Hoechest dye
33258, H2O2 and anti-PUMA antibody were purchased
from Sigma-Aldrich (St-Louis, MI, USA). Anti-procaspase
3, 9, 8 antibodies were purchased from Cell Signaling
(Beverly, MA). Anti-P53 (DO-1) antibody, anti-Sp1 (pol-
yclonal antibody PEP2) antibody, anti-actin antibody and
secondary antibodies were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). Sp1 siRNA, control
siRNA, siRNA Transfection reagent and siRNA Transfec-
tion Medium were purchased from Santa Cruz Biotech-
nology. All other chemicals were of analytical grade.
Plasmids
The -336/+157 and -36/+157 PUMA-Luc reporter plas-
mids were a kind gift from Dr. Bert Vogelstein (Johns
Hopkins University, Baltimore, MD, U.S.A.). The (-336/
+157 -126/-25) PUMA-Luc plasmid was constructed by
digesting the -336/+157 PUMA-Luc plasmid with Sac II
and SmalI, and re-ligation according to reference 16.
pSVβ-Galactosidase plasmid was purchased from
promega.
Cell culture, transient transfections and luciferase assays
The human colorectal cancer cell lines LoVo and HCT116
were obtained from American Type Culture Collection
(Manassaas, VA), LoVo PUMA_AS cells was established as
described in a previous study[15]. The LoVo cells and
LoVo PUMA_AS cells were cultured in 25 cm2 flasks in
1640 medium contained 10% (v/v) FBS with or without
G418 (600 μg/ml). Cells were maintained at 37°C in a
humidified 5% CO2 atmosphere until confluency and
subcultured (1:10 split ratio) using trypsin (0.05% w/v)/
EDTA (0.02% w/v). Cells for examination were grown in
six-well cluster dishes. All treatments were carried out on
cells at 70–80% confluence, PFT-α (20 μM) and Mithr.A
(200 ng/ml) were added an hour before addition of H2O2.
Transient transfection was performed in 6-well plates
using Lipofectamin 2000(Invitrogen) according to the
manufacture's instructions. Cells were transfected with
0.5 μg luciferase reporter plasmid and 0.1 μg pSVβ, trans-
fections were allowed to proceed for 3 hours in the
absence of serum and the cells recovered in medium sup-
plemented with reduced serum level(2.5%) for 21 hours.
Luciferase assays were performed 48 hours later using the
luciferase assay kit from Promega, according to the manu-
facture's instructions (Promega, Madison, WI). The β-
galactosidase reporter pSVβ (Promega) was included to
control for transfection efficiency.
Reverse transcriptase-polymerase chain reaction
0.5 μg total RNA was isolated from the cells using TRIZOL
(Gibco). PUMA mRNA expression was determined by RT-
PCR analysis using a RevertAid First Strand cDNA Synthe-
sis Kit (MBI) and PCR kit (SBS Genetech Co. Ltd., Beijing,
China). The two gene-specific primers used for amplifica-
tion were as follows: (upper) gacgacctcaacgcacagta and
(lower) ccagggtgtcaggaggtg. PCR products were electro-
phoresed in 1.5% agarose gel. Beta-actin mRNA was alsoJournal of Experimental & Clinical Cancer Research 2008, 27:44 http://www.jeccr.com/content/27/1/44
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amplified as an internal control. The experiment was per-
formed twice.
Western blotting analysis of PUMA, p53, Sp1, procaspase 
3,9 and procaspase 8 expression
Western blotting analysis was assessed according to the
protocol described before[15]. In brief, cells were washed
with ice-cold PBS twice and lysed with ice-cold lysis
buffer. Protein samples (15 μg) were separated by SDS/
PAGE (12% acrylamide gel) using a Bio-Rad Mini-Protean
III system. Proteins were transferred to PVDF membranes
and the membranes were blocked for 1 hour at room tem-
perature with TBST. Blots were then incubated at room
temperature with primary antibodies (1:500 dilution)
and then primary antibodies were removed and the blots
were extensively washed with TBS/Tween 20 for three
times. Blots were then incubated for 1 hour at room tem-
perature with the secondary antibodies (1: 2000 dilu-
tion). Then blots were extensively washed as above for 1
hour and developed using the Enhanced Chemilumines-
cence detection system and quantified using the Gene-
Tools systems.
siRNA transfection
siRNA transfection was performed according to the man-
ufacture's instructions. In brief, LoVo cells were seeded at
a density of 2 × 105 per well in 2 ml antibiotic-free 1640
medium supplemented with 10% FBS in a six well tissue
plate. The cells were incubated at 37°C in a CO2 incubator
until the cells were 70% confluent. siRNA duplex solution
(6  μl of siRNA duplex in 100 μl siRNA Transfection
Medium) was added directly to the dilute Transfection
Reagent (6 μl of siRNA Transfection Reagent in 100 μl
siRNA Transfection Medium). The mixture was mixed and
incubated at room temperature for 30 minutes. Then the
mixture and 0.8 ml siRNA Transfection Medium were
mixed and added to the cells. The cells were incubated 6
hours and the mixture was removed. H2O2 (0.64 mM) was
added 24 hours later and remained for 15 minutes. West-
ern blotting analysis was performed 48 hours post-trans-
fection.
Hoechst 33258 staining for apoptosis
For analysis of apoptosis by nuclear staining with Hoechst
dye 33258 (Sigma Chemical Co.), cells were stimulated
according to experimental protocols, washed once with
PBS, and then fixed with pre-cooled methanol 500 μl/well
for 10 minutes. After fixation, cells were washed once with
PBS, stained with 1 μM Hoechst dye 33258 for 10 min-
utes, and then washed once with PBS and distilled water.
Apoptosis was indicated by the presence of condensed or
fragmented nuclei which bind the Hoechst dye 33258
with high affinity. For analysis of cell structure by phot-
omicroscopy, coverslips were washed once with PBS and
then inverted and mounted on to glass slides. Cells were
visualized using an Olympus microscope. Two hundred
cells in three randomly chosen fields were counted and
scored for the incidence of apoptotic chromatin changes
under fluorescence microscopy.
Statistical analysis
All data are presented as mean values ± standard deviation
(SD) of three independent experiments. Comparison of
the effects of various treatments was performed using fac-
tor analysis, one-way ANOVA analysis of variance and a
two-tailed t-test. Difference with a p value of < 0.05 were
considered statistically significant.
Results
H2O2 induces time- and dose-dependent PUMA expression 
and apoptosis in colorectal cancer cells
To assess the effects of H2O2 on PUMA expression, we
exposed LoVo cells to a dose range of H2O2 at different
time points, and we measured PUMA expression by West-
ern blotting analysis 24 hours later. Exposure to H2O2 was
found to induce PUMA expression significantly already
after 5 minutes. A maximal upregualtion by approxi-
mately 50% was observed after 15 minutes (Figure 1A). A
dose-range identified that H2O2 induced PUMA expres-
sion maximally at a concentration of 0.64 mM (Figure
1B).
To assess the effects of H2O2 on apoptosis in colorectal
cancer, we exposed LoVo cells to a dose range of H2O2 at
different time points, and we measured apoptosis by
Hoechst 33258 dye 24 hours later. As shown in Figure 1C,
H2O2-induced apoptosis increased significantly at 15
minutes and decreased after 30 minutes. And apoptosis
increased significantly when LoVo cells were treated for 15
minutes with 0.64 mM and 0.80 mM of H2O2. (Figure
1D).
H2O2 up-regulates PUMA expression at the transcriptional 
level in colorectal cancer cells
To investigate whether H2O2 increases PUMA expression
at the mRNA level, we treated LoVo cells with a dose and
time range of H2O2 and performed a standard RT-PCR
experiment. As seen in Figure 2A and 2B, H2O2 increased
PUMA mRNA in a dose- and time- dependent manner.
Therefore, the data suggested that H2O2  up-regulated
PUMA expression at transcriptional level.
Activation of p53 by e.g. DNA-damaging agents is fol-
lowed by an induction of PUMA expression, leading to
enhanced recruitment of endogenous p53 protein to the
PUMA gene promoter. To test this, we used a -336/+157
PUMA-Luc reporter plasmid, which contains a set of 10
potential binding sites for Sp family proteins in the prox-Journal of Experimental & Clinical Cancer Research 2008, 27:44 http://www.jeccr.com/content/27/1/44
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imal region between nucleotides-120 and 18, flanked by
two p53-recognition sequences at the 5' end between
nucleotides -229/-209 and -145/-126. LoVo cells were
transfected with this vector, 24 hours before H2O2 (0.64
mM) was added. As shown in Figure 2C, a significant
transactivation of this promoter was observed after expo-
sure to H2O2 for 15 minutes. These results suggest that
H2O2 can influence endogenous PUMA levels by regulat-
ing PUMA promoter activity.
H2O2-induced apoptosis is abrogated by suppression of 
PUMA expression
To investigate whether PUMA is required for cells to
undergo apoptosis, we made use of LoVo PUMA_AS cells,
are stable cell line with low expression of PUMA[15]. We
reasoned that these cells may differentially respond to oxi-
dative stress as compared with their normal counterparts
(colorectal cancer LoVo cells). As shown in Figure 3,
induction of apoptosis by H2O2 is significantly hampered
H2O2 induced PUMA expression and apoptosis in a time-and dose-dependent manner in colorectal cancer cells Figure 1
H2O2 induced PUMA expression and apoptosis in a time-and dose-dependent manner in colorectal cancer 
cells. (A) LoVo Cells were treated with 0.64 mM H2O2 at different time point and PUMA expression was assessed by Western 
blotting analysis. (B) Western blotting analysis of a dose-range of a 15 minute H2O2 exposure of LoVo cells. Data was pre-
sented as the percentage of the basal level of PUMA expression (control = 100%) in the absence of H2O2 and expressed as 
mean ± SD of three independent experiments. (C, D) LoVo Cells were treated with a time- and dose- range of H2O2 as indi-
cated in Figure 1C, D, apoptosis was assessed by Hoechst dye 33258. Data was presented as the number of apoptosis per 200 
cells in three different areas. Statistical significance as compared to control cells (*p < 0.05, #p > 0.05).Journal of Experimental & Clinical Cancer Research 2008, 27:44 http://www.jeccr.com/content/27/1/44
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H2O2 regulated PUMA expression at transcriptional level Figure 2
H2O2 regulated PUMA expression at transcriptional level. (A, B) Dose and time response of LoVo cells treated with 
H2O2. PUMA mRNA expression was detected by RT-PCR using 0.5 μg total RNA. Beta-actin mRNA was amplified as an inter-
nal control. (C) LoVo cells were transiently transfected with the -336/+157 PUMA-luc reporter plasmid (0.5 μg). H2O2 (0.64 
mM) was added to the indicated samples 24 hours post-transfection and exposure was continued for 15 minutes. The pSVβ-
Galactosidase plasmid (0.1 μg) was included in each sample for normalization of transfection variability. Luciferase activity was 
determined in cell lysates 48 hours following the transfection and the values (mean ± SD, *p < 0.05) from at least two inde-
pendent expression performed in duplicate are shown in the form of a bargraph.Journal of Experimental & Clinical Cancer Research 2008, 27:44 http://www.jeccr.com/content/27/1/44
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in LoVo PUMA_AS cells, as compared with induction in
control LoVo cells (p < 0.05).
Sp1 is required for the transactivation of the human PUMA 
promoter by p53
The promoter of PUMA gene contains a cluster of GC-rich
motifs flanked by two p53-recognition motifs at the 5'
end. The p53 sites are located at distal regions relative to
the proximal Sp1 sites. The family member Sp1 has been
shown to mediate oxidative stress-induced gene transcrip-
tion. To determine the role of Sp1 in H2O2-induced
PUMA expression, we examined the activity of a series of
PUMA promoter truncation mutants[16] after H2O2 treat-
ment Compared with cells transfected with -336/+157
PUMA-Luc, the transactivation level of cells transfected
with -336/+157 -126/-25PUMA-Luc was lower, but the
difference was not significant (p > 0.05). Transfection
with the -36/+157PUMA-Luc vector induced a significant
decrease of transactivation (#p < 0.05, Figure 4A).
PFT-α is a stable, water soluble inhibitor of p53-depend-
ent apoptosis and was also shown to reduce the activation
of p53-regulated genes [17]. Mithramycin A (Mithr.A) is a
drug which has been clinically used in the therapies of sev-
eral type of cancer and Paget's disease. It binds to GC-rich
regions in chromatin and interferes with the transcription
of genes that bear GC-rich motifs in their promoters
including Sp1[18]. Previous study suggested that Mithr.A
also activates endogenous p53 protein and has no effect
on the expression of endogenous Sp1 genes. To identify
the effects of Mithr.A on p53 and Sp1 expression, Mithr.A
(200 ng/ml) was added to LoVo cells 24 hours before p53
and Sp1 expression was assessed by Western blotting anal-
ysis. As shown in Figure 4B, Mithr.A had no effects on p53
expression, but suppressed the expression of Sp1. Mithr.A
also abrogated the Sp1 expression induced by H2O2 (Fig-
ure 4C). Similarly, PFT-α (20 μM) abrogated p53 expres-
sion induced by H2O2.
To determine the effects of Mithr.A and PFT-α on PUMA
expression, Mithr.A and PFT-α were added an hour before
H2O2 treatment. As shown in Figure 4D, PUMA expres-
sion was found to be suppressed by exposure to Mithr.A
as well as to PFT-α, and more markedly when both com-
pounds were combined. To determine whether these
effects were cell-specific, we also assessed PUMA expres-
sion in HCT116 cells and gained the same results (Figure
4E). To confirm the role of Sp1 in H2O2-induced PUMA
expression furthermore, we suppressed Sp1 expression by
transfecting Sp1 siRNA and our data suggested that Sp1
siRNA abrogated H2O2-induced PUMA expression (Figure
4F).
To understand the mechanism of Mithr.A and PFT-α
action, we tested the ability of Mithr.A and PFT-α to
inhibit PUMA promoter activation induced by H2O2. As
shown in Figure 4G, Mithr.A caused a decrease in PUMA
promoter activity induced by H2O2 but the difference was
not significant (p < 0.05). PFT-α, in contrast, caused a sig-
nificant decrease in PUMA expression (p < 140.05). Com-
bination of PFT-α and Mithr.A caused a significant
enhancement of decrease in PUMA promoter activity (p <
0.05). Factor analysis (n = 6) indicated that Mithr.A and
PFT-α have synergistic effects on H2O2-induced PUMA
promoter activation (F = 5.480, p = 0.030).
H2O2-induced apoptosis is abrogated by Mithr.A and PFT-
α through a mitochondrial pathway
To test whether a decrease in the expression of PUMA con-
tributed to a decrease in the apoptosis of the cells, apop-
tosis assays were performed. We assessed the impact of
Mithr.A and PFT-α treatment on H2O2-induced apoptosis
in colorectal cancer cells. As shown in Figure 5A, Mithr.A
caused a decrease in H2O2-induced apoptosis but the dif-
ference was not significant with untreated cells, while PFT-
α caused a significant decrease. Compared with PFT-α
alone, treatment with the combination of both com-
pounds caused a significant decrease in H2O2-induced
apoptosis.
Suppression of PUMA expression abrogated the apoptosis  induced by H2O2 Figure 3
Suppression of PUMA expression abrogated the 
apoptosis induced by H2O2. LoVo PUMA wild-type cells 
and LoVo PUMA_AS cells were treated with H2O2 (0.64 
mM) for 15 minutes and allowed to recover for 24 hours. 
Hoechst dye 33258 was used to detect apoptosis. Data are 
presented as mean number of apoptotic cells (mean ± SD) 
from three independent experiments. Significant difference 
between LoVo PUMA wild-type cells and LoVo PUMA_AS 
cells is indicated by * (p < 0.05).Journal of Experimental & Clinical Cancer Research 2008, 27:44 http://www.jeccr.com/content/27/1/44
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Sp1 is required for the transactivation of the human PUMA promotor by H2O2 Figure 4
Sp1 is required for the transactivation of the human PUMA promotor by H2O2. (A) LoVo cells were transiently 
transfected with reporter plasmids (0.5 μg). 0.64 mM H2O2 was added 24 hours post-transfection for 15 minutes. The pSVβ-
Galactosidase plasmid (0.1 μg) was included in each sample for normalization of transfection variability. Luciferase activity was 
determined in cell lysates 48 hours following the transfection and the values (mean ± SD), from at least two independent 
experiments performed in duplicate (*p > 0.05,-336/+157 -126/-25PUMA-Luc vs-136/+157 PUMA-Luc, #p < 0.05,-36/
+157PUMA-Luc vs-336/+157 -126/-25PUMA-Luc). (B) Mithr.A (200 ng/ml) was added to LoVo cells. Extracts from the treated 
or untreated LoVo cells were subjected to immunoblotting using antibodies against p53, Sp1 and actin. (C) LoVo cells were 
treated with 20 μM PFT-α and/or 200 ng/ml Mithr.A an hour before 0.64 mM H2O2 added. Cell extracts were analysed for the 
expression of endogenous p53, Sp1 and actin as indicated by immunoblotting. (D, E) LoVo and HCT 116 cells were treated 
with 20 μM PFT-α and/or 200 ng/ml Mithr.A an hour before 0.64 mM H2O2 added. Cell extracts were analysed for the expres-
sion of PUMA as indicated by immunoblotting. (F) H2O2 -induced PUMA expression was abrogated by transfecting Sp1 siRNA. 
LoVo cells were transfected with control siRNA or Sp1 siRNA and H2O2 was added 24 hours post-transfection. PUMA 
expression was detected by Western blotting analysis 48 hours post-transfection. (G) LoVo cells were transiently transfected 
with the -336/+157 PUMA-Luc reporter plasmid, 0.64 mM H2O2 was added 24 hours post-transfection and remained for 15 
minutes. Mithr.A (200 ng/ml) and/or PFT-α (20 μM) was added an hour before H2O2. Luciferase activity was determined in cell 
lysates 48 hours following the transfection and the values (mean ± SD.) from at least two in dependent expression performed 
in duplicate are shown in the form of a bargraph, *p < 0.05, significant difference between cells treated as indicated in Figure 
4G, # p > 0.05, no significant difference between cells treated as indicated in Figure 4G (factor analysis, n = 6).Journal of Experimental & Clinical Cancer Research 2008, 27:44 http://www.jeccr.com/content/27/1/44
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PFT-α and Mithr.A decreased H2O2-induced apoptosis in a mitochondrial pathway Figure 5
PFT-α and Mithr.A decreased H2O2-induced apoptosis in a mitochondrial pathway. (A) LoVo cells were treated 
with PFT-α (20 μM), Mithr.A (200 ng/ml) an hour before H2O2 (0.64 mM) was added. Hoechst dye 33258 was used to detect 
apoptosis (* represents significance p < 0.05, # represents significance p > 0.05). (B) LoVo cells were treated with PFT-α (20 
μM), Mithr.A (200 ng/ml) an hour before H2O2 (0.64 mM) was added. Total extracts were then prepared and assayed for the 
level of the protein by immunoblot. Similar results were observed in two separate experiments.Journal of Experimental & Clinical Cancer Research 2008, 27:44 http://www.jeccr.com/content/27/1/44
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PUMA is a mitochondrial protein involved in apoptosis in
a mitochondrial pathway, leading to activation of caspase
9 and caspase 3 but not caspase 8. To assess the impact of
Mithr.A and PFT-α treatment on these events, total cell
extracts were prepared from H2O2, Mithr.A and PFT-α
treated cells, and procaspase 3, procaspase 9 and procas-
pase 8 levels were monitored by Western blotting analysis.
As shown in Figure 5B, increased levels of procaspase 3
and 9 were observed in Mithr.A and PFT-α treated cells,
while effects on procaspase 8 were absent.
Discussion
The generation of large amounts of reactive oxygen inter-
mediates may contribute to the ability of some tumors to
mutate, inhibit antiproteases and injure local tissues [19].
On the other hand, the production of ROS during the
catabolism of tumor and chemotherapy leads to apopto-
sis and benefits in the process of the clearance of tumor
cells. In the present study, we found that H2O2 up-regu-
lated PUMA expression and induced apoptosis in colorec-
tal cancer LoVo cells. Suppression of PUMA expression
abrogated H2O2-induced apoptosis. To further elucidate
the mechanism responsible for the changes in amounts of
PUMA, we determined levels of PUMA mRNA by RT-PCR.
Our data suggested that PUMA expression at the mRNA
level increased and transcription activity of PUMA was
upregulated by administration of H2O2 especially at doses
between 0.04 and 0.64 mM in colorectal cancer LoVo
cells.
PUMA is essential in the process of apoptosis induction by
exogenous or endogenous p53 [20-22]. However, many
studies described that there were other factors involved in
the regulation of PUMA expression, either in a p53-
dependent or independent manner including our previ-
ous report. For example, Tzippi et al [23] reported E2F1
upregulated the expression of PUMA through a direct
transcriptional mechanism and increased PUMA levels
mediated E2F1-induced apoptosis. Furthermore, Kout-
sodontis et al [16] found that the PUMA promoter con-
tains a cluster of GC-rich motifs flanked by two p53-
recognition motifs and a series of Sp1 recognition sites at
the 5'-end. This was identified by searching the 5'-flanking
sequence of PUMA with Tfsearch software http://
molsun1.cbrc.aist.go.jp/research/db/TFSEARCH.html.
The same report also suggests that the Sp family was essen-
tial for the cellular response to p53 activation by genoto-
xic stress such as ROS [24,25]. This urged us to
hypothesize that Sp1 plays a role in H2O2-induced PUMA
expression and apoptosis.
To investigate the role of Sp1 on H2O2-induced PUMA
expression, Mithr.A (a DNA-binding antitumor agent)
[26] and PFT-α (a selective p53 inhibitor), were used for
pharmacological intervention both in LoVo cells (p53
mutation) and HCT116 cells (p53 wide type). Sp1 siRNA
was also used to confirm the result. Our data suggest that
Sp1 plays a role in H2O2-induced PUMA expression and
regulated it at the transcriptional level. This regulation is
not cell specific in LoVo cells and HCT116 cells. To deter-
mine whether H2O2 could induce PUMA expression in
p53 mutant cell lines, we detect the expression of PUMA
in H2O2-treated SW480 cells(p53 mutated colorectal can-
cer cells) and LoVo p53- cells (established in our previous
study). Our data showed that no much difference was
found in H2O2 -treated cells and untreated cells (data not
show) and this induction was p53-dependent.
Sp1 and p53 could regulate PUMA expression synergisti-
cally in H2O2-treated LoVo colorectal cancer cells. More
interesting, Mithr.A was used as an antitumor agent and
has been used in the clinic for several types of cancer. Lee
et al [27] reported that it sensitized cancer cells to TRAIL-
mediated apoptosis by down-regulation of XIAP gene pro-
moter through Sp1 sites. Our data suggest that Mithr.A
decreases apoptosis in colorectal cancer cells through
inhibiting PUMA promoter activity, which may limit the
application of Mithr.A in colorectal cancer therapy.
To assess whether inhibiting Sp1 binding to the PUMA
promoter by Mithr.A contributed to a decrease of apopto-
sis induced by H2O2, Hoechst dye 33258 staining was car-
ried out. Our data showed that combination of Mithr.A
and PFT-α abrogated H2O2-induced apoptosis signifi-
cantly better, as compared with PFT-α alone. PUMA
induction results in Bax multimerizaion, mitochondia-
dependent death, the release of cytochrome C and caspase
9 induction leading to apoptosis [14]. Our data showed
an increase in expression of procaspase 3, procaspase 9
and suggested an decrease of caspase 3 and 9. Therefore,
Sp1 activity may be functionally linked to the effects of
H2O2 on PUMA.
In summary, a novel mechanism of PUMA stimulation by
H2O2 in colorectal cancer LoVo cells has been demon-
strated. The results suggest that H2O2-induced up-regula-
tion of PUMA is partly due to Sp1 transcription factor
except for p53. These results may provide an insight into
the molecular control of H2O2-induced PUMA expression
in colorectal cancer cells through Sp1 binding sites.
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